HISTOPATHOLOGIC DETERMINANTS OF HUMAN NEPHROLITHIASIS

人类肾结石的组织病理学决定因素

基本信息

  • 批准号:
    7490030
  • 负责人:
  • 金额:
    $ 4.68万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2007
  • 资助国家:
    美国
  • 起止时间:
    2007-09-01 至 2010-08-31
  • 项目状态:
    已结题

项目摘要

Our histopathologic studies performed during the previous grant period have characterized the histopathological and mineral composition in three groups of stone formers: common idiopathic calcium oxalate stone formers, patients with stones due to intestinal bypass surgery for obesity and brushite stone formers (as well as non-stone formers) to test the hypothesis that Randall's plaque, calcium phosphate deposits in kidneys of patients with calcium renal stones, arise in unique anatomical regions of the kidney, their formation conditioned by specific stone-forming pathophysiologies. We were amazed at the finding, in that, each group of stone formers had a different and unique histopathologic pattern of crystal desposition while all intraparenchymal and interstitial sites of crystalline material were hydroxyapatite, yet another surprise. Because we were so highly successful in the last funding period in identifying a clear set of surgical/ morphological/metabolic characteristics in these three different groups of human stone formers (CaOx, intestinal bypass for obesity and brushite) and will extend these analyses to new groups of stone formers: apatite (including RTAs) stone formers, primary hyperparathyroidism with kidney stones, ileostomy with kidney stones, cystine stone formers, uric acid stones, bariatric patients with stones and CaOx stone formers with high urine pH (> pH 6.3) using histopathology,mu CT, and mu FTIR. In addition, we will seek to test a new set of hypotheses concerning the mechanisms of stone formation. First, we will test the hypothesis that the progression of HA accumulation occurs along a specific segment of the loops of Henle, the thin descending limb. Second, the mechanism of crystal particle formation and coalescence in the common CaOx patients will be determined by quantitative TEM and tetracycline studies. Third, test the hypothesis that there are candidate proteins that either promote or inhibit crystal nucleation and growth within the papillary interstitium or tubular lumens. This will be done using TEM immunohistochemical analysis to define the interaction of osteopontin, prothrombin fragment 1,fetuin-A and bikunin on interstitial and the plaque-stone interface. Fourth, we will use RT-PCR techniques to detect transcripts for the presence of osteoblast-like activity. Lastly, we will examine the idea that a loss of fluid pH control in the inner medullary collecting ducts due to SWL injury may result in an alkalization of the bulk urine and, therefore, give insights into the mechanisms of stone formation in brushite stone disease.
我们的组织病理学研究在上一个资助期进行的特点是, 三组结石形成者的组织病理学和矿物组成:常见的特发性草酸钙结石形成者、因肥胖而接受肠旁路手术的结石患者和透钙磷石结石形成者(以及非结石形成者)来检验以下假设:兰德尔斑块,即钙肾结石患者肾脏中的磷酸钙沉积物,出现在肾脏的独特解剖区域中,它们的形成受特定的结石形成病理生理学的制约。我们对这一发现感到惊讶,因为每组结石形成者具有不同且独特的晶体沉积组织病理学模式,而所有实质内和间质部位的晶体物质均为羟基磷灰石,这是另一个惊喜。因为我们在上一个资助期非常成功地确定了一套清晰的外科/ 这三组不同的人类结石形成者的形态/代谢特征(CaOx,肥胖症和透钙磷石的肠旁路),并将这些分析扩展到新的结石形成者组:磷灰石(包括RTA)结石形成者、原发性甲状旁腺功能亢进伴肾结石、回肠造口术伴肾结石、胱氨酸结石形成者、尿酸结石,使用组织病理学、mu CT和mu FTIR对患有结石的肥胖患者和具有高尿液pH(> pH 6.3)的CaOx结石形成者进行了研究。此外,我们将试图测试一套新的假设有关的机制,石头的形成。首先,我们将测试假设, HA积累的进展发生在沿着Henle袢的特定段,即细的下行支。第二,晶体颗粒的形成和合并在常见的CaOx患者的机制将通过定量TEM和四环素的研究。第三,检验是否存在促进或抑制乳头状小管或肾小管内晶体成核和生长的候选蛋白质这一假设。这将使用TEM免疫组织化学分析来确定骨桥蛋白、凝血酶原片段1、胎球蛋白-A和bikunin在间质和斑块-结石界面上的相互作用。第四,我们将使用RT-PCR技术来检测转录本是否存在成骨细胞样活性。最后,我们将研究的想法,液体pH值控制的损失,由于SWL损伤可能会导致大量尿液的碱化,因此,给透钙磷石结石病的结石形成机制的见解。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

ANDREW P EVAN其他文献

ANDREW P EVAN的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('ANDREW P EVAN', 18)}}的其他基金

PATHOPHYSIOLOGY AND HISTOPATHOLOGY OF NEPHROLITHIASIS
肾结石的病理生理学和组织病理学
  • 批准号:
    8231181
  • 财政年份:
    2011
  • 资助金额:
    $ 4.68万
  • 项目类别:
PATHOLOGY CORE
病理学核心
  • 批准号:
    8231135
  • 财政年份:
    2011
  • 资助金额:
    $ 4.68万
  • 项目类别:
IKSI: 2nd International Urolithiasis Research Symposium
IKSI:第二届国际尿石症研究研讨会
  • 批准号:
    7540831
  • 财政年份:
    2008
  • 资助金额:
    $ 4.68万
  • 项目类别:
CORE--PATHOLOGY
核心--病理学
  • 批准号:
    7490032
  • 财政年份:
    2007
  • 资助金额:
    $ 4.68万
  • 项目类别:
Strategies of Improved shock wave lithotripsy
改进冲击波碎石术的策略
  • 批准号:
    7499948
  • 财政年份:
    2007
  • 资助金额:
    $ 4.68万
  • 项目类别:
RISK FACTORS FOR SHOCK WAVE LITHOTRIPSY-INDUCED INJURY
冲击波碎石损伤的危险因素
  • 批准号:
    7493010
  • 财政年份:
    2007
  • 资助金额:
    $ 4.68万
  • 项目类别:
HISTOPATHOLOGIC DETERMINANTS OF HUMAN NEPHROLITHIASIS
人类肾结石的组织病理学决定因素
  • 批准号:
    7311588
  • 财政年份:
    2006
  • 资助金额:
    $ 4.68万
  • 项目类别:
CORE--PATHOLOGY
核心--病理学
  • 批准号:
    7311590
  • 财政年份:
    2006
  • 资助金额:
    $ 4.68万
  • 项目类别:
IKSI: 1st Annual International Urolithiasis Research Symposium
IKSI:第一届年度国际尿石症研究研讨会
  • 批准号:
    7278406
  • 财政年份:
    2006
  • 资助金额:
    $ 4.68万
  • 项目类别:
CORE--PATHOLOGY
核心--病理学
  • 批准号:
    6898586
  • 财政年份:
    2005
  • 资助金额:
    $ 4.68万
  • 项目类别:

相似海外基金

AMAZE : Advanced MOF-loaded Air-pollution control and Zero-emission Electrospun filters
AMAZE:先进的 MOF 负载空气污染控制和零排放静电纺丝过滤器
  • 批准号:
    10078131
  • 财政年份:
    2023
  • 资助金额:
    $ 4.68万
  • 项目类别:
    Collaborative R&D
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了